These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6038600)

  • 1. Hydroxyethyl starch (HES) and bleeding. An experimental investigation of its effect on hemostasis.
    Garzon AA; Cheng C; Lerner B; Lichtenstein S; Karlson KE
    J Trauma; 1967 Sep; 7(5):757-66. PubMed ID: 6038600
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
    Jones PA; Tomasic M; Gentry PA
    Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

  • 5. BLEEDING VOLUME INDICES OF HYDROXYETHYL STARCH, DEXTRAN, BLOOD, AND GLUCOSE.
    THOMPSON WL; WAYT DH; WALTON RP
    Proc Soc Exp Biol Med; 1964 Feb; 115():474-7. PubMed ID: 14121642
    [No Abstract]   [Full Text] [Related]  

  • 6. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution.
    Haas T; Fries D; Holz C; Innerhofer P; Streif W; Klingler A; Hanke A; Velik-Salchner C
    Anesth Analg; 2008 Apr; 106(4):1078-86, table of contents. PubMed ID: 18349176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C; Calatzis A; Welsch U; Heindl B
    Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hydroxyethyl-starch on the intra- and postoperative behaviour of haemostasis.
    Müller N; Popov-Cenić S; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):460-2. PubMed ID: 75006
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydroxyethyl starch on hemostasis.
    Cheng C; Lerner B; Lichtenstein S; Karlson KE; Garzon AA
    Surg Forum; 1966; 17():48-50. PubMed ID: 5921022
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of somatostatin on haemostasis in dogs.
    Gabryelewicz A; Prokopowicz J; Hnidec O; Wolosowicz N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):125-31. PubMed ID: 6164606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged bleeding times and hypofibrinogenemia in dogs after infusion of hydroxyethyl starch and dextran.
    Thompson WL; Gadsden RH
    Transfusion; 1965; 5(5):440-6. PubMed ID: 5831657
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander).
    Solanke TF
    Br Med J; 1968 Sep; 3(5621):783-5. PubMed ID: 4877738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care.
    Arnaud F; Fasipe D; Philbin N; Rice J; Flournoy WS; Ahlers S; McCarron R; Freilich D
    Transfusion; 2007 Nov; 47(11):2098-109. PubMed ID: 17958540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN.
    GARZON AA; FINK LH; SHAFTAN GW; KARLSON KE
    J Thorac Cardiovasc Surg; 1964 Dec; 48():873-80. PubMed ID: 14239975
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic defects in massive transfusion: rapid diagnosis and management.
    Reiss RF
    Am J Crit Care; 2000 May; 9(3):158-65; quiz 166-7. PubMed ID: 10800600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of various hemostyptics on hemorrhage, blood coagulation, prothrombin time and thrombocyte count].
    KLEINSORGE H; MUHS C
    Z Gesamte Inn Med; 1953 Jun; 8(12):532-42. PubMed ID: 13170080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the changes in the hemostatic system in dogs immediate by following massive blood transfusion].
    Balakina TA; Gorbunova NA
    Probl Gematol Pereliv Krovi; 1981 Mar; 26(3):30-3. PubMed ID: 7232377
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.